Delivery Order SPE2DB20D3103-SPE2DB25FM4D3

Award Date 1/22/25
Potential Completion Date 1/23/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award to AmerisourceBergen Drug Corp is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The delivery order is for 4,563,337,707 units of 5mg oxycodone hydrochloride immediate-release tablets, with a ceiling value of $2,965.32. This pharmaceutical product supports medical care for military personnel, veterans, and other federal beneficiaries....
This federal contract award, valued at $1,729.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price valued at $1,347.18. The award was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,564,167,843 units of Oxycodone HCl (IR) 5 mg tablets. The contract has an ultimate completion date of March 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,448.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,115,975 units of Oxycodone HCl (IR) 5 mg tablets, a pain management medication, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract is a Delivery Order with a Firm Fixed Price pricing type and has...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,018.34 firm fixed-price delivery order contract is for the supply of 4,558,083,526 tablets of 10 mg Oxycodone HCL ER, a pain management medication. The contract has an ultimate completion date of August 15, 2022 and does not appear to have any set-aside requirements. AmerisourceBergen holds a larger...
This federal contract award, valued at $1,884.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,250,443 units of Oxycodone Hydrochloride 5 mg/5 ml oral solution, a pharmaceutical product used for pain management. This is a firm-fixed price delivery order contract that runs through February 13, 2025. No set-aside designation was used for this award....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of 4,566,768,044 units of oxycodone hydrochloride 5 mg tablets. The $1,617.80 firm fixed price contract was awarded on December 19, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 20, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This is a Delivery Order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,171.75, is for the delivery of 500 tablets of 5 mg Oxycodone HCL, a prescription pain medication. The award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, that allows the agency to efficiently procure a range of pharmaceutical and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,478.32 firm fixed-price delivery order is for the supply of 4,560,670,376 tablets of Oxycodone HCL ER 20 mg. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides 4,555,372,493 units of Oxycodone HCL 5 mg tablets to the Defense Logistics Agency (DLA). The $2,257.83 firm fixed-price delivery order has a completion date of November 10, 2021. The contract is not designated as a set-aside. Amerisourcebergen, a subsidiary of Cencora, Inc., holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM4D3
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,460.22, is for the delivery of 4,567,012,938 units of 5 mg Oxycodone HCL immediate-release tablets. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular award is not designated as a set-aside contract.

Generated 4/23/25, 10:54 AM